FIELD: medicine.
SUBSTANCE: ultrasound examination of mammary glands is performed. Local areas of density in adipose tissue without a capsule are determined with clear traceable contours. If they are available, women are classified as being at risk of high cholesterol level and metabolic disorders.
EFFECT: method allows to identify the risk of high cholesterol and the presence of metabolic disorders in women at early stages due to ultrasound examination of the mammary glands with identification of the most significant indicators.
2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF RISK EVALUATION OF METABOLIC SYNDROME IN PATIENTS WITH CHRONIC CHOLECYSTITIS | 2009 |
|
RU2403868C1 |
| METHOD FOR PATIENT-SPECIFIC PREDICTION OF OESTROGEN-DEPENDENT DISEASES IN HEALTHY FEMALES AND FEMALES WITH CARDIOVASCULAR RISK FACTORS AGED 35-45 YEARS | 2013 |
|
RU2536829C1 |
| METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
| METHOD OF ESTIMATING RISK OF DEVELOPMENT OF UNFAVOURABLE CARDIOVASCULAR EVENTS IN PATIENTS WITH ISCHEMIC HEART DISEASE SUBJECTED TO ENDOVASCULAR MYOCARDIUM REVASCULARISATION DURING ONE YEAR AFTER INTERFERENCE | 2010 |
|
RU2444297C1 |
| METHOD OF TREATING ABDOMINAL OBESITY IN CASE OF METABOLIC SYNDROME | 2013 |
|
RU2548709C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPMENT OF INSULIN RESISTANCE | 2019 |
|
RU2748034C2 |
| METHOD FOR INDIVIDUAL ASSESSMENT OF SEVERITY OF COMBINED PATHOLOGY IN THERAPEUTIC PATIENTS | 2024 |
|
RU2830411C1 |
| METHOD FOR METABOLIC SYNDROME PREDICTION IN THE II TRIMESTER OF PREGNANCY | 2016 |
|
RU2617182C1 |
| METHOD OF DIAGNOSING AND TREATING ENDOTHELIAL DYSFUNCTION IN METABOLIC DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE OF SECOND FUNCTIONAL CLASS | 2020 |
|
RU2737416C1 |
| METHOD FOR DISLIPIDEMIA PREVENTION | 2016 |
|
RU2621152C1 |
